FY2019 EPS Estimates for MAXIMUS, Inc. (NYSE:MMS) Raised by Analyst

MAXIMUS, Inc. (NYSE:MMS) – Stock analysts at First Analysis upped their FY2019 earnings per share estimates for MAXIMUS in a research note issued to investors on Sunday, August 11th. First Analysis analyst F. Sparacino now forecasts that the health services provider will post earnings of $3.75 per share for the year, up from their previous forecast of $3.70. First Analysis also issued estimates for MAXIMUS’s Q4 2019 earnings at $0.96 EPS, Q1 2020 earnings at $0.97 EPS and FY2020 earnings at $4.14 EPS.

Several other equities analysts have also recently weighed in on MMS. ValuEngine cut MAXIMUS from a “buy” rating to a “hold” rating in a research note on Friday, June 28th. Wells Fargo & Co reaffirmed a “market perform” rating and set a $83.00 target price on shares of MAXIMUS in a research report on Friday, August 9th. Canaccord Genuity raised their target price on MAXIMUS from $72.00 to $77.00 and gave the company a “hold” rating in a research report on Tuesday. Finally, Zacks Investment Research raised MAXIMUS from a “hold” rating to a “buy” rating and set a $75.00 target price for the company in a research report on Monday, May 27th.

Shares of NYSE:MMS opened at $75.92 on Wednesday. The stock’s fifty day simple moving average is $73.74 and its two-hundred day simple moving average is $72.41. MAXIMUS has a 1-year low of $60.00 and a 1-year high of $80.83. The stock has a market cap of $4.86 billion, a PE ratio of 22.33, a price-to-earnings-growth ratio of 2.04 and a beta of 0.88.

MAXIMUS (NYSE:MMS) last issued its quarterly earnings data on Thursday, August 8th. The health services provider reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.04. MAXIMUS had a return on equity of 20.72% and a net margin of 8.44%. The business had revenue of $730.70 million for the quarter, compared to analysts’ expectations of $754.81 million. During the same period last year, the business earned $0.91 EPS. The business’s revenue was up 22.2% on a year-over-year basis.

A number of institutional investors and hedge funds have recently made changes to their positions in MMS. Advisory Services Network LLC increased its holdings in MAXIMUS by 499.0% in the 2nd quarter. Advisory Services Network LLC now owns 593 shares of the health services provider’s stock worth $43,000 after acquiring an additional 494 shares during the last quarter. Mckinley Capital Management LLC Delaware purchased a new stake in MAXIMUS in the 1st quarter worth about $44,000. Advisor Group Inc. increased its holdings in MAXIMUS by 47.3% in the 4th quarter. Advisor Group Inc. now owns 869 shares of the health services provider’s stock worth $56,000 after acquiring an additional 279 shares during the last quarter. Quantamental Technologies LLC purchased a new stake in MAXIMUS in the 2nd quarter worth about $71,000. Finally, Signaturefd LLC increased its holdings in MAXIMUS by 19.6% in the 2nd quarter. Signaturefd LLC now owns 1,145 shares of the health services provider’s stock worth $83,000 after acquiring an additional 188 shares during the last quarter. 94.53% of the stock is owned by institutional investors.

In other news, Vice Chairman Richard A. Montoni sold 12,000 shares of the firm’s stock in a transaction on Tuesday, June 11th. The stock was sold at an average price of $74.07, for a total transaction of $888,840.00. Following the completion of the sale, the insider now directly owns 377,874 shares of the company’s stock, valued at approximately $27,989,127.18. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Vice Chairman Richard A. Montoni sold 35,000 shares of the firm’s stock in a transaction on Thursday, June 13th. The shares were sold at an average price of $74.68, for a total value of $2,613,800.00. Following the sale, the insider now directly owns 377,874 shares of the company’s stock, valued at $28,219,630.32. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 48,000 shares of company stock valued at $3,575,540. Insiders own 2.20% of the company’s stock.

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 30th. Stockholders of record on Thursday, August 15th will be given a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 1.32%. The ex-dividend date of this dividend is Wednesday, August 14th. MAXIMUS’s dividend payout ratio is presently 29.41%.

About MAXIMUS

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

Recommended Story: Insider Trading – What You Need to Know

Earnings History and Estimates for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.